scorecardresearch
Wednesday, September 10, 2025
TopicVaccine

Topic: Vaccine

Not Oxford lab, not US company, Covid solution will come from India, China pharma industry

Fast and mass pharma production in India and China is crucial if the coronavirus pandemic is to be brought under control.

Are people who have had Covid-19 immune? Perhaps not

What needs to happen now is a series of studies to determine whether the presence of antibodies is associated with protection against re-infection with SARS-CoV-2.

Covid vaccine makers may need to infect subjects to get results

As the infection rate changes, companies running drug trials will face a new problem — not enough test subjects in their regions.

Indian vaccine ventures with global partners could move to human trials soon: VijayRaghavan

At least 14 vaccine candidates being developed solely by Indian players, but none ready for human trials stage yet, Principal Scientific Adviser K. VijayRaghavan says.

Why vaccines should not be immune to market forces

Market prices for vaccines could ensure additional production, help differentiate between vaccines, and even allocation of resources.

Green shoots emerge in world economy as virus lockdowns ease

Indicators such as electricity demand and traffic congestions point to a modest 'lift of lows', as economic recovery remains uneven in the absence of a vaccine.

There will be more than one coronavirus vaccine, and that will be a merry situation

With over 70 vaccine candidates, the end of the Covid crisis will likely be multiple vaccines, some more traditional and others based on emerging technologies.

US pharma giant Merck hopes to beat coronavirus with a pill and two vaccines

Merck bought rights to develop a promising antiviral and will work with partners to advance candidate vaccines based on the technology behind Ebola and measles immunizations.

Xi Jinping is seeking to beat Trump in the race for a coronavirus vaccine

China has promised to share any successful vaccine globally, and would wield immense geopolitical clout if it produces one of the world’s first working shots.

Chinese vaccine shows promise in early human trial, generates immune response against Covid

The vaccine developed by CanSino Biologics is the first candidate to be tested in human trials.

On Camera

Tamil Nadu politics is fracturing. Vijay entry can shake things up

There is an overall sense of ennui with the cynical, established and entrenched parties and politicking in the state.

What happens to Haryana real estate agents now? Govt agency HSVP to act as broker, take commissions

Gurugram: Stirring a storm in Haryana's real estate circles, the Haryana Shehri Vikas Pradhikaran (HSVP)—the state's urban development agency—has taken on the role of...

Denmark tweaks its banned exports list, delivery of critical system for Tejas MK 1A starts 

HAL has produced 10 Tejas Mk 1A and is now awaiting further deliveries of engines from American firm GE—delayed by two and half years, so far.

Punjab is fast becoming the new Northeast. And there’s a message in it for Modi

In its toughest time in decades because of floods, Punjab would’ve expected PM Modi to visit. If he has the time for a Bihar tour, why not a short visit to next-door Punjab?